| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |